At Palmetto Retina Center, Drs. Lloyd Clark and Jack Wells offer the most comprehensive and state of the art care in the treatment of vitreous and retinal diseases in South Carolina. Our practice is limited to patients with retinal diseases and our efforts are concentrated on providing our patients with the best quality care in a compassionate, caring environment.
Your visit to Palmetto Retina Center will involve a thorough retinal examination by our doctors followed by diagnostic imaging of the retina to determine the best course of treatment.
Retinal photography and fluorescein angiography is performed using either the Topcon Imagenet system or Heidelberg Retinal Angiograph 2. The latter allows specialized autofluorescence imaging and high speed indocyanine green angiography in patients with age-related macular degeneration. No other practice in South Carolina has this capability, which allows treatment in many patients with the wet form of macular degeneration that is not possible using conventional forms of retinal imaging such as fluorescein angiography. We also use the latest optical coherence tomography imaging to diagnose and manage macular edema from diabetes and other disorders.
Our practice is also dedicated to the advancement of new treatments for retinal diseases. We are involved in multiple clinical trials of the newest therapies for age-related macular degeneration, diabetic retinopathy, and retinal vein occlusions. Please refer to our clinical trials page for more information.
We offer the best surgical care for treatment of retinal detachment, proliferative diabetic retinopathy complicated by traction retinal detachment and vitreous hemorrhage.
Protocol VGFT-OD-0605: A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration. Sub-investigator. July 2007. Sponsor: Regeneron.
CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy (CABERNET). A Randomized, Prospective, Active Controlled, Study of the Epi-Rad90™ Ophthalmic System for the Treatment of Subfoveal Choroidal Neovascularization Associated with Wet Age-Related Macular Degeneration. Sub-investigator. July 2007. Sponsor: Neovista.
Molecular Prognostic Testing for Eye Melanoma. Validation of a Molecular Test for Predicting Metastasis in Patients with Uveal Melanoma. Multicenter, prospective study designed to analyze uveal melanomas and suspicious uveal nevi for gene expression profiles that predict metastatic risk. Sub-investigator. January 2007.
OPHTEC Model 311 Artificial Iris Lens For the Treatment of Visual Disturbances Resulting From Partial or Total Absence of the Human Iris. Continued Access Compassionate Use Study. Sub-investigator. March 2007.
AMD DOC Study. Detection of Onset of New Choroidal Using Preferential Hyperacuity Perimeter. Sub-investigator. March 2007.
VERTACL Study. Multi-center study investigating the use of Verteporfin and Triamcinolone Acetonide for AMD. Sub-investigator. January 2007.
Combined Years of Practice
Clinical Trials Participated
Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.